01 May 2018

White Paper : Improving Access to Innovative Cancer Therapies in Canada

White Paper “Improving Access to Innovative Cancer Therapies in Canada” According to 2017 Canadian Cancer Society statistics, almost half of all Canadians  will develop cancer in their lifetime. Cancer remains the leading cause of death in Canada, responsible for 30.2% of lives ...

15 Feb 2018

PMPRB Consultation Response – Canada Gazette

A group of Canadian patient organizations, mainly but not solely comprised of cancer groups, responded to the pre-consultation call for input from the Patented Medicine Prices Review Board (PMPRB) on proposed amendments to the Regulations to the Patent Act. The response submitted by the patient or...

28 Jun 2017

Recommendations on PMPRB Regulations June 28, 2017

Our health care system is complex; no one would argue to the contrary. There are many key decision makers at either federal, national or provincial levels that are responsible for the health care services Canadians receive from coast to coast to coast. Health Canada holds different responsibilities ...